ORKA Stock Price
Oruka Therapeutics, Inc.
ORKA stock price is $104.56 (+1.65% on the day), giving Oruka Therapeutics, Inc. a market cap of $6.92B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
ORKA Stock Overview
- Price
- $104.56
- Previous close
- $102.86
- Open
- $104.56
- Market cap
- $6.92B
- 52-week range
- $25.23 - $115.52
- 1-year price target
- $144.43
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- Nasdaq
- MarketXLS Rank
- 54
About Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 1 trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORKA | $104.56 | +1.7% | 1.60M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Oruka Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW